article · 2012
Phase I study of PM00104 (Zalypsis®) administered as a 1-hour weekly infusion resting every fourth week in patients with advanced solid tumors
18 citationsDOI: https://doi.org/10.1007/s10637-012-9843-5
Article
Article detail, metadata, authors, and available full-text links.
Paper reader
Loading paper...